Collegium Pharma (COLL) Tops Q4 EPS by 3c

March 7, 2018 4:03 PM

Collegium Pharma (NASDAQ: COLL) reported Q4 EPS of ($0.54), $0.03 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $9.88 million.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

Categories

Earnings Guidance

Next Articles